Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementation
John R. Gosney, Luis Paz‐Ares, Pasi A. Jänne, et al.
ESMO Open (2023) Vol. 8, Iss. 4, pp. 101587-101587
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Deciphering Lung Adenocarcinoma Progression Through Molecular Insights: The Challenges and Potential of Radiomics and Machine Learning
Ritu R. Gill, Despina Kontos
Journal of Thoracic Oncology (2025) Vol. 20, Iss. 1, pp. 20-22
Closed Access
Addressing challenges in the implementation of precision oncology: An in-depth examination of limitations and disparities in the treatment of non-small cell lung cancer in the Brazilian public healthcare system (SUS)
Luma Princess Schneider, Jean Henri Maselli-Schoueri, Barbara de Souza Gutierres Aguiar, et al.
Global Public Health (2025) Vol. 20, Iss. 1
Open Access
Proposal of real-world solutions for the implementation of predictive biomarker testing in patients with operable non-small cell lung cancer
Paul Hofman, Petros Christopoulos, Nicky D’Haene, et al.
Lung Cancer (2025), pp. 108107-108107
Closed Access
Results of a modified Delphi consensus on the optimal testing pathway for oesophago-gastric cancer care in the UK
Manuel Rodriguez‐Justo, Wasat Mansoor, Thomas Bird, et al.
BMJ Open (2025) Vol. 15, Iss. 2, pp. e094343-e094343
Open Access
Emerging molecular testing paradigms in non-small cell lung cancer management—current perspectives and recommendations
Frédérique Penault‐Llorca, Mark A. Socinski
The Oncologist (2025)
Open Access
Next-Generation Sequencing Trends among Adult Patients with Select Advanced Tumor Types
Andrea Ferreira‐Gonzalez, Brian Hocum, Gilbert Ko, et al.
Journal of Molecular Diagnostics (2024) Vol. 26, Iss. 4, pp. 292-303
Open Access | Times Cited: 3
The World Health Organization Reporting System for Lung Cytopathology–A Review of the First Edition
Darin Dolezal, Ivana Kholová, Guoping Cai
Journal of Clinical and Translational Pathology (2024) Vol. 4, Iss. 1, pp. 18-35
Open Access | Times Cited: 2
Rapid and reliable testing for clinically actionable EGFR mutations in non-small cell lung cancer using the Idylla TM platform: a real-world two-center experience in Greece
Kleita Michaelidou, Ioannis Karniadakis, Varvara Pantelaion, et al.
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 1-2, pp. 89-98
Closed Access | Times Cited: 2
Referred molecular testing as a barrier to optimal treatment decision making in metastatic non‐small cell lung cancer: Experience at a tertiary academic institution in Canada
Grace K. Grafham, Kenneth J. Craddock, Weei‐Yuarn Huang, et al.
Cancer Medicine (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 2
Expanding Broad Molecular Reflex Testing in Non-Small Cell Lung Cancer to Squamous Histology
Martin Zacharias, Selma Konjić, Nikolaus Kratochwill, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 903-903
Open Access | Times Cited: 2
Enhancing Lung Cancer Care in Portugal: Bridging Gaps for Improved Patient Outcomes
Raquel Ramos, Conceição Souto Moura, Mariana Fernandes Costa, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 5, pp. 446-446
Open Access | Times Cited: 2
Lung adenocarcinoma with EGFR L858R-K860I and L858R-L861F doublet mutations from which the L858R mutation is undetectable through the cobas EGFR mutation test v2
Chi-Hsuan Wu, Man-San Zhang, Yen‐Lin Huang, et al.
Pathology - Research and Practice (2024) Vol. 257, pp. 155304-155304
Closed Access | Times Cited: 1
Real-World Treatment Patterns and Timeliness of Clinical Care Pathway for Non-Small Cell Lung Cancer Patients in Austria: The PRATER Retrospective Study
Maximilian J. Hochmair, Angelika Terbuch, David Lang, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2586-2586
Open Access | Times Cited: 1
Liquid and Tissue Biopsies for Lung Cancer: Algorithms and Perspectives
Paul Hofman
Cancers (2024) Vol. 16, Iss. 19, pp. 3340-3340
Open Access | Times Cited: 1
The relevance of the reference range for EGFR testing in non-small cell lung cancer patients
Pasquale Pisapia, Alessandro Russo, Caterina De Luca, et al.
Lung Cancer (2024) Vol. 198, pp. 108002-108002
Open Access | Times Cited: 1
Update on Practical Management of Early-Stage Non-Small Cell Lung Cancer (NSCLC): A Report from the Ontario Forum
Parneet Cheema, Paul F. Wheatley‐Price, Matthew J. Cecchini, et al.
Current Oncology (2024) Vol. 31, Iss. 11, pp. 6979-6999
Open Access | Times Cited: 1
How to Keep Up With Molecular Testing and Targeted Therapies in Lung Cancer
Jyoti Malhotra, Edward S. Kim
JCO Oncology Practice (2024) Vol. 20, Iss. 11, pp. 1471-1480
Closed Access | Times Cited: 1
Implementation of the clinical practice of liquid biopsies for thoracic oncology the experience of the RespirERA university hospital institute (Nice, France)
Paul Hofman
The Journal of Liquid Biopsy (2023) Vol. 1, pp. 100004-100004
Open Access | Times Cited: 2
Avances y desafíos locales en el diagnóstico molecular de tumores sólidos: una mirada sanitaria hacia la oncología de precisión en Chile
Katherine Marcelain, Carolina Selman-Bravo, Benjamín García-Bloj, et al.
Revista médica de Chile (2023) Vol. 151, Iss. 10, pp. 1344-1360
Open Access | Times Cited: 2
How Molecular and Ancillary Tests Can Help in Challenging Cytopathology Cases: Insights from the International Molecular Cytopathology Meeting
Elena Vigliar, Claudio Bellevicine, Gennaro Acanfora, et al.
Journal of Molecular Pathology (2024) Vol. 5, Iss. 2, pp. 228-237
Open Access
Lung Cancer in Ghana
Jane Afriyie-Mensah, Mary-Ann Dadzie, Verna Vanderpuye, et al.
Journal of Thoracic Oncology (2024) Vol. 19, Iss. 7, pp. 966-972
Closed Access
Healthcare provider practices and perceptions of biomarker testing in U.S. Veterans with non-small cell lung cancer
Elena Vlachos, Adam H. Fox, John Dell’Italia, et al.
CHEST Journal (2024)
Closed Access
Next step of molecular pathology: next-generation sequencing in cytology
Ricella Souza da Silva, Fernando Schmitt
Journal of Pathology and Translational Medicine (2024) Vol. 58, Iss. 6, pp. 291-298
Open Access
Tissue navigator, an important position in the Pathology laboratory in the Precision Medicine era
Fabio Távora, Jaime Correia de Sousa
ESMO Open (2023) Vol. 8, Iss. 5, pp. 101827-101827
Open Access | Times Cited: 1
Response to letter entitled: letter comments on: Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementation
John R. Gosney, Solange Peters
ESMO Open (2023) Vol. 8, Iss. 5, pp. 101828-101828
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top